Abstract
With the importance of producing quality products and processes, and the increase in regulatory scrutiny of all aspects of the pharmaceutical product development and manufacturing cycle, companies across the industry are examining their approaches to managing quality. This study was aimed at understanding how some of the leading firms in the industry structure their quality assurance (QA) functions to meet the current challenges and to identify structural characteristics that were common for success.Companies appear to be centralizing the management of QA functions on a global basis, and the preferred organizational approach for these global organizations is to combine the Good Laboratory Practices (GLP), Good Clinical Practices (GCP), and Good Manufacturing Practices (GMP) functions. More often than not, if all three groups are combined, they report into research and development (R&D) management. Three criteria emerge as the critical success factors to consider when organizing QA functions: impact, indep...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.